World Pharma News / Search results for teva

1
Vote

Teva to acquire CoGenesys with a purchase price of $400 million cash

Posted by worldpharmanews 307 days ago (http://www.worldpharmanews.com)
Category: Financial | Tags: teva cogenesys

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that it has entered into a definitive agreement to acquire CoGenesys, Inc., a privately- read more »
Discuss Add this link to... Bury

1
Vote

Trial Date Set For SEROQUEL® Patent Litigation

Posted by worldpharmanews 265 days ago (http://www.worldpharmanews.com)
Category: Product | Tags: astrazeneca seroquel teva sandoz

AstraZeneca announced a trial date has been set for patent litigation in the US District Court for the District of New Jersey against Teva Pharmaceutical Industries Ltd. and Sandoz, Inc. alleging inf read more »
Discuss Add this link to... Bury

1
Vote

Teva Reports Second Quarter 2008 Results - Record Quarterly Sales of $2,823 Million

Posted by worldpharmanews 112 days ago (http://www.worldpharmanews.com)
Category: Financial | Tags: teva

Net sales for the second quarter of 2008 increased 18 percent to $2,823 million, compared to $2,386 million in the second quarter of 2007. Net income for the second quarter of 2008 totaled $539 milli read more »
Discuss Add this link to... Bury

1
Vote

US Court Denies Teva's Motion For Summary Judgment In Pulmicort Respules Patent Litigation

Posted by worldpharmanews 69 days ago (http://www.worldpharmanews.com)
Category: Corporate | Tags: astrazeneca teva pulmicort respules

AstraZeneca today announced that the US District Court for the District of New Jersey has denied Teva's Motion for Summary Judgment of no infringement in the PULMICORT RESPULES (budesonide inhalatio read more »
Discuss Add this link to... Bury

2
Vote

AstraZeneca granted Temporary Restraining Order in PULMICORT RESPULES patent litigation

Posted by worldpharmanews 13 days ago (http://www.worldpharmanews.com)
Category: Corporate | Tags: astrazeneca teva pulmicort respules

On 19 November 2008, AstraZeneca was granted a Temporary Restraining Order (TRO) by the United States District Court for the District of New Jersey, halting sales of Teva's budesonide inhalation sus read more »
Discuss Add this link to... Bury

1
Vote

AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva

Posted by worldpharmanews 7 days ago (http://www.worldpharmanews.com)
Category: Corporate | Tags: astrazeneca pulmicort teva

AstraZeneca has entered into a settlement agreement in its Pulmicort Respules patent infringement litigation against Ivax Pharmaceuticals, Inc., a wholly owned subsidiary of Teva Pharmaceuticals USA. read more »
Discuss Add this link to... Bury